ClinicalTrials.Veeva

Menu

An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence

University of Southern California logo

University of Southern California

Status

Enrolling

Conditions

Head and Neck Carcinoma

Treatments

Other: Non-Interventional Study

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT06420219
NCI-2024-01559 (Registry Identifier)
P30CA014089 (U.S. NIH Grant/Contract)
7H-23-4 (Other Identifier)

Details and patient eligibility

About

This study evaluates the cell and biomarkers associated with the aggressive behavior of cancer.

Full description

PRIMARY OBJECTIVE:

I. High-resolution single-cell profiling of Cancer-associated fibroblasts (CAFs) in Human papillomavirus (HPV)+ Oropharyngeal Squamous Cell Carcinoma (OPSCC) and metastatic lymph nodes.

OUTLINE: This is an observational study.

Patients undergo photography, blood sample collection, tissue collection and have their medical records reviewed on study.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis/disease status: New diagnosis of head and neck cancer
  • Allowable type and amount of prior therapy: No prior treatment
  • Age ≥ 18 years.
  • Ability to understand and the willingness to sign a written informed consent.

Exclusion criteria

  • Patients who have had treatment of head and neck cancer

Trial design

50 participants in 1 patient group

Observational
Description:
Patients undergo photography, blood sample collection, tissue collection and have their medical records reviewed on study.
Treatment:
Other: Non-Interventional Study

Trial contacts and locations

1

Loading...

Central trial contact

Sandy Tran, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems